Loading...
CD 123 is a membrane biomarker and a therapeutic target in hematologic malignancies
Recent studies indicate that abnormalities of the alpha-chain of the interleukin-3 receptor (IL-3RA or CD123) are frequently observed in some leukemic disorders and may contribute to the proliferative advantage of leukemic cells. This review analyzes the studies indicating that CD123 is overexpresse...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BioMed Central
2014
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3928610/ https://ncbi.nlm.nih.gov/pubmed/24513123 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2050-7771-2-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|